Search

Elfatih Omer Elzein

from Tracy, CA
Age ~62

Elfatih Elzein Phones & Addresses

  • 759 W Bonaventure Ave, Tracy, CA 95391 (510) 851-1988
  • Mountain House, CA
  • Gilbert, AZ
  • 1003 Tom Seaver Pl, Round Rock, TX 78664
  • Palo Alto, CA
  • Fremont, CA
  • Brooklyn Center, MN
  • Maricopa, AZ
  • Pittsburgh, PA
  • San Mateo, CA

Work

Company: Cv therapeutics Position: Senior scientist at cv therapeutics inc

Languages

English

Interests

Boating • Exercise • Electronics • Outdoors • Investing • Sports

Industries

Pharmaceuticals

Resumes

Resumes

Elfatih Elzein Photo 1

Senior Scientist At Cv Therapeutics Inc

View page
Location:
759 west Bonaventure Ave, Mountain House, CA 95391
Industry:
Pharmaceuticals
Work:
Cv Therapeutics
Senior Scientist at Cv Therapeutics Inc
Interests:
Boating
Exercise
Electronics
Outdoors
Investing
Sports
Languages:
English

Publications

Us Patents

Thiophene A2A Receptor Agonists

View page
US Patent:
6440948, Aug 27, 2002
Filed:
Jun 20, 2000
Appl. No.:
09/597436
Inventors:
Jeff A. Zablocki - Mountain View CA
Elfatih O. Elzein - Fremont CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 3170
US Classification:
514 46, 536 2762
Abstract:
2-(3-,4-(substituted)-5-alkylthienyl)adenosines and the 5â-uronic acid amide analogues thereof having the following formula: are disclosed herein. Additionally disclosed are medicinal methods of treatment wherein the adenosine A agonist activity of the noted compounds stimulates mammalian coronary vasodilation for therapeutic purposes and for purposes of imaging the heart.

Substituted Alkyl Piperazine Derivatives

View page
US Patent:
6451798, Sep 17, 2002
Filed:
Feb 22, 2001
Appl. No.:
09/792167
Inventors:
Vaibhav Varkhedkar - Sunnyvale CA
Venkata P. Palle - Mountain View CA
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Brent K. Blackburn - Los Altos CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Aralkyl Substituted Piperazine Compounds

View page
US Patent:
6552023, Apr 22, 2003
Filed:
Feb 22, 2001
Appl. No.:
09/791133
Inventors:
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Brent K. Blackburn - Los Altos CA
Tim Marquart - San Francisco CA
Prabha N. Ibrahim - Mountain View CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212, 51425411, 544377, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Heteroaryl Alkyl Piperazine Derivatives

View page
US Patent:
6573264, Jun 3, 2003
Filed:
Oct 23, 2000
Appl. No.:
09/694155
Inventors:
Jeff Zablocki - Mountain View CA
Prabha N. Ibrahim - Mountain View CA
Kevin Shenk - Palo Alto CA
Elfatih Elzein - Fremont CA
Venkata Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31496
US Classification:
514249, 51425301, 51425306, 51425402, 51425409, 544354, 544360, 544363, 544368, 544373
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Substituted Piperazine Compounds

View page
US Patent:
6677336, Jan 13, 2004
Filed:
Feb 22, 2001
Appl. No.:
09/791134
Inventors:
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Grigory Nudelman - Pacifica CA
Tim Marquart - San Francisco CA
Brent K. Blackburn - Los Altos CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
5142358, 51425401, 51425502, 514249, 514412, 544121, 544372, 544384, 544400, 544231, 544353, 548543
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Substituted Piperazine Compounds

View page
US Patent:
6677343, Jan 13, 2004
Filed:
Feb 22, 2001
Appl. No.:
09/791262
Inventors:
Brent K. Blackburn - Los Altos CA
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Grigory Nudelman - Pacifica CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425411, 51425501, 51425409, 544373, 544377, 544391
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

A2B Adenosine Receptor Antagonists

View page
US Patent:
6825349, Nov 30, 2004
Filed:
Nov 8, 2002
Appl. No.:
10/290921
Inventors:
Rao Kalla - Mountain View CA
Thao Perry - San Jose CA
Elfatih Elzein - Fremont CA
Vaibhav Varkhedkar - San Diego CA
Xiaofen Li - Palo Alto CA
Prabha Ibrahim - Mountain View CA
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO
Jeff Zablocki - Mountain View CA
Assignee:
CV Therapeutics Inc. - Palo Alto CA
International Classification:
C07D47312
US Classification:
544267, 544269, 544270, 544271, 544272
Abstract:
Disclosed are novel A adenosine receptor antagonists compounds having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

Aralkyl Substituted Piperazine Compounds

View page
US Patent:
6852723, Feb 8, 2005
Filed:
Feb 11, 2003
Appl. No.:
10/365344
Inventors:
Jeff Zablocki - Mountain View CA, US
Elfatih Elzein - Fremont CA, US
Brent K. Blackburn - Los Altos CA, US
Tim Marquart - Mountain View CA, US
Prabha N. Ibrahim - Mountain View CA, US
Venkata P. Palle - Gurgaon, IN
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K031/495
A61K031/496
US Classification:
51425212, 51425411, 544377, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetal's (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.
Elfatih Omer Elzein from Tracy, CA, age ~62 Get Report